Aegon's first-half 2026 results paint a picture of a company deliberately reshaping itself ahead of a planned move of its primary stock listing to the United States by January 1, 2028. According to analysts at Berenberg, a European investment bank, the update reinforces the strategic logic behind the shift — and it could have a significant impact on who owns the stock and which businesses the insurer keeps.
What's driving the move?
The core of the argument is about the shareholder base. Berenberg estimates that passive ownership — shares held by index-tracking funds that automatically buy whatever is in a benchmark — could rise from roughly 15% today to around 30% once Aegon's main listing is in the US. That's a big change. Index funds are price-sensitive and generally don't make active judgments about a company's strategy; they simply mirror the index. A larger passive presence can make a stock more liquid and more attractive to institutional investors, but it also means the company's management must pay close attention to what index providers decide.
The reason a US listing would boost passive ownership is straightforward: US indices are among the most widely tracked in the world, and many global funds benchmark against them. If Aegon is included in major US indices, those funds would automatically buy the stock. That could provide a steady source of demand and potentially support the share price over time.
Slimming down the legacy book
Berenberg also notes that Aegon's H1 2026 update strengthens the case for continuing to trim older, slower-growing lines of business, particularly long-term care insurance. Long-term care is a classic legacy product: it was sold heavily in the past, but it ties up capital and carries long-dated liabilities that are hard to manage. Many insurers have been trying to reduce their exposure to such lines, either by selling them off, reinsuring them, or simply running them off.
For Aegon, the logic is that a leaner, more focused company would be more attractive to US investors, who tend to favor simpler, higher-growth businesses. By shedding legacy lines, Aegon can free up capital and reduce complexity, making it easier to tell a clean growth story to a new audience.
This is not a new trend. Insurers across Europe and the US have been grappling with legacy books for years, and the shift toward a US listing is part of a broader strategy to reposition Aegon as a more modern, capital-efficient player. The company has already made significant moves in this direction, and the H1 2026 results appear to confirm that the strategy is on track.
What it means for investors
For everyday investors, the key takeaway is that Aegon's ownership structure is likely to change, and that could have implications for how the stock trades. A higher passive ownership share often means lower volatility, because index funds buy and sell based on index changes rather than on news or earnings. But it also means that the stock's performance will be more closely tied to the overall market and to index inclusion decisions.
Investors should also watch how Aegon manages its legacy lines. If the company successfully reduces its long-term care exposure, it could improve its return on equity and free up cash for dividends or buybacks. On the other hand, if the process drags on or costs more than expected, it could weigh on results.
Berenberg's note is just one analyst's view, but it highlights a broader point: a company's listing location is not just a matter of paperwork. It can change the entire dynamics of the shareholder base, influence strategic decisions, and ultimately affect how the stock is valued.
For now, Aegon's path to a US listing by 2028 seems clear, and the H1 2026 results have reinforced the rationale. Investors will be watching the next few quarters to see if the company can execute on its plan to slim down and reposition itself for a new chapter in the US market.
Related reading: Berenberg lifts ASR Nederland target and Texas Stock Exchange lands first ETF listings.
